FERG.UK

12,070

+3.34%↑

FERG.UK

12,070

+3.34%↑

FERG.UK

12,070

+3.34%↑

FERG.UK

12,070

+3.34%↑

FERG.UK

12,070

+3.34%↑

Search

ConvaTec Group PLC

Închisă

SectorFinanțe

239 1.44

Rezumat

Modificarea prețului

24h

Curent

Minim

232

Maxim

241

Indicatori cheie

By Trading Economics

Venit

79M

Vânzări

1.1B

P/E

Medie Sector

36.743

22.015

EPS

0.07

Randament dividend

1.96

Marjă de profit

7.059

Angajați

10,489

EBITDA

251M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+27.34% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.96%

3.90%

Statistici piață

By TradingEconomics

Capitalizare de piață

203M

5.3B

Deschiderea anterioară

237.56

Închiderea anterioară

239

Sentimentul știrilor

By Acuity

37%

63%

149 / 542 Clasament în Finance

ConvaTec Group PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

26 feb. 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Comparație

Modificare preț

ConvaTec Group PLC Așteptări

Obiectiv de preț

By TipRanks

27.34% sus

Prognoză pe 12 luni

Medie 318.86 GBX  27.34%

Maxim 375 GBX

Minim 305 GBX

În baza a 7 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruConvaTec Group PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

7 ratings

7

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

149 / 542 Clasament în Finanțe

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.